hsa-miR-205-5p

ncRNA information

ncRNA name

hsa-miR-205-5p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PTEN/JNK/ANXA3 signaling pathway

Cancer information

Cancer name

Hepatocellular Carcinoma

Cancer site

Liver

Treatment information

Treatment type

Chemotherapy

Drug

5-Fluorouracil

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Inhibition of miR-205-5p may reverse chemotherapeutic resistance to 5-Fu, and this may occur via the PTEN/JNK/ANXA3 pathway.

Tissue resource

normal liver cell lines LO2

hepatoma cell lines Bel-7402

hepatoma cell lines SMMC-7721

hepatoma cell lines HCCLM3

hepatoma cell lines MHCC97-H

hepatoma cell lines MHCC97-L

hepatoma cell lines Huh-7

Experiment

qRT-PCR,Western blot


Institute

KeyGen Biotech Co., Ltd.

the Second Affiliated Hospital of Dalian Medical University

Country

China

Continent

Asia